Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau -- Ignore unavailable to you. Want to Upgrade?

To: Findit who wrote (1201)	6/4/2002 10:01:45 AM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2243

It's an election year. Pharmaceuticals have had a big target painted on them for some time, and President Bush, in all his wisdom, has left FDA without a Commissioner. >> nice to know there is hope for my beaten down bio-tech portfolio << Hope? Sure..... medicines have value. Some markets are huge, and lots of them look huge in relation to the small research premiums. It's often very, very easy to recoup losses rapidly in biotech. However, those of us who thought that the dip in '98 was not going to be long-lasting got killed. Hedge funds are rolling in profit, throwing bucks against the sector with impunity. They can withstand an enormous squeeze in any given issue, and not even blink. Pick stocks wisely, with good timing. You'll notice that my recent timing was lousy. On a scale of one to ten, it registered as "stinking".